Effect of EZH2 regulation of the JAK2/STAT3 signaling pathway on proliferation and apoptosis in non-small cell lung cancer cells
Enhancer of zeste homolog 2 (EZH2) is frequently overexpressed in non-small cell lung cancer (NSCLC) and is associated with aggressive tumor behavior and poor patient prognosis. However, the molecular mechanisms through which EZH2 drives NSCLC progression, particularly its interplay with major oncogenic signaling casca...